Valuation Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:00 29/07/2026 BST			5-day change	1st Jan Change
2.870 ^USD	0.00%		-3.37%	+4.36%

07-28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55.03	35.12	112.8	215.6	204.4	327.3	-	-
Change	-	-36.19%	221.19%	91.16%	-5.18%	60.11%	-	-
Enterprise Value (EV) ¹	55.03	35.12	112.8	-8.207	61.26	140.2	15.01	140.7
Change	-	-36.19%	221.19%	-107.28%	846.48%	128.84%	-89.29%	837.19%
P/E	-12.9x	-4.94x	-2.36x	-2.59x	-1.96x	-2.6x	-2.53x	-2.69x
PBR	-	-	-	0.78x	0.99x	1.27x	1.09x	1.53x
PEG	-	-0.1x	-0x	0.1x	-0.1x	0.1x	-0.93x	0.45x
Capitalization / Revenue	5.47x	9.89x	78.7x	148x	231x	773x	671x	24.3x
EV / Revenue	5.47x	9.89x	78.7x	-5.64x	69.3x	331x	30.8x	10.4x
EV / EBITDA	-19.1x	-	-	0.13x	-0.56x	-1.11x	-0.1x	-0.92x
EV / EBIT	-16x	-	-2.75x	0.12x	-0.54x	-1.12x	-0.1x	-0.97x
EV / FCF	-	-	-2.97x	0.11x	-0.64x	-1.34x	-0.11x	-0.94x
FCF Yield	-	-	-33.7%	886%	-155%	-74.4%	-924%	-107%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.3	-0.5	-1.7	-1.23	-1.4	-1.104	-1.134	-1.066
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10.05	3.552	1.434	1.454	0.884	0.4232	0.4875	13.49
EBITDA ¹	-2.874	-	-	-64.49	-110.3	-126.9	-144.2	-153
EBIT ¹	-3.446	-	-40.94	-66.8	-113.6	-125.4	-144.8	-144.5
Net income ¹	-3.39	-	-46.51	-79.28	-103.1	-120.1	-138.1	-137
Net Debt ¹	-	-	-	-223.8	-143.2	-187.1	-312.3	-186.7
Reference price ²	3.878	2.471	4.020	3.190	2.750	2.870	2.870	2.870
Nbr of stocks (in thousands)	14,192	14,211	28,057	67,588	74,338	114,046	-	-
Announcement Date	21/09/21	01/05/23	28/03/24	26/03/25	16/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PERSPECTIVE THERAPEUTICS, INC.	-2.6x	331.29x	-1.11x	-.--%	327M
LONZA GROUP AG	32.72x	5.89x	17.49x	0.98%	47.88B
IQVIA HOLDINGS INC.	31.16x	3.12x	13.46x	-.--%	40.55B
REVOLUTION MEDICINES, INC.	-22.95x	343.53x	-20.98x	-.--%	39.09B
BEONE MEDICINES AG	49x	5.01x	32.38x	-.--%	36.75B
CELLTRION, INC.	27.11x	7.84x	19.63x	0.43%	27.96B
MEDPACE HOLDINGS, INC.	32.47x	5.31x	24.11x	-.--%	15.94B
ICON PUBLIC LIMITED COMPANY	25.48x	2.01x	12.17x	-.--%	13.81B
EUROFINS SCIENTIFIC SE	22.79x	2x	8.65x	1.16%	13.55B
Average	21.69x	78.44x	11.76x	0.29%	26.2B
Weighted average by Cap.	24.04x	61.43x	12.60x	0.32%